使-2 ():

Matthew Suen1, Jo-Anne Manski-Nankervis1, Caroline McBride1

  • 1Department of General Practice and Primary Care, University of Melbourne, Parkville, Australia.

PubMed
概括

在初级保健中实施一种新的-葡萄糖共运输体2 (SGLT2) 抑制剂的软件模块显示了对2型糖尿病管理的潜在益处. 然而,竞争优先事项和员工参与等障碍阻碍了其有效使用.